Rosen Law Firm encourages UP Fintech Holding Limited investors to seek information regarding a securities class action investigation, amid rising coverage interest.
Browsing Category
Deal News & Trends
491 posts
CAR Investors Have Opportunity To Lead Avis Budget Group, Inc. Securities Fraud Lawsuit Against Pentwater Capital Management LP
Investors in CAR stock may have the opportunity to initiate a securities fraud lawsuit against Pentwater Capital Management, amid emerging concerns over Avis Budget Group.
Technology Empowers Elegance: LEPAS Redefines The New Energy Mobility Experience
LEPAS introduces a new energy mobility experience emphasizing technology and elegance, signaling a shift in sustainable transportation.
Niutech Signs Agreement With Global Energy Leader For SAF Plant
Niutech has signed a deal with a major energy company to develop a plastic waste pyrolysis line for sustainable aviation fuel production, marking a significant step in green energy.
HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit Of ORPATHYS® Plus TAGRISSO® In Treatment-Naïve Patients With MET-Overexpressing EGFR-mutated Lung Cancer In China
HUTCHMED announces that its SANOVO trial shows notable progression-free survival benefits for ORPATHYS® combined with TAGRISSO® in lung cancer patients in China.
TCL Electronics Reports Strong Interim Results For 2026
TCL Electronics (01070.HK) announced significant growth in its interim financial results for 2026, highlighting a positive trend amid market fluctuations.
EBA E-mail Alert 27 August, 2026
European Banking Authority issues urgent email alert on August 27, 2026, prompting widespread attention amid rising financial sector concerns.
SPJ Sunshine State Awards 2026 Winners Announced
The Society of Professional Journalists’ Sunshine State Awards announced the 2026 winners, recognizing excellence in Florida journalism.
ChowChow Cloud International Holdings Limited Provides Response To Unusual Market Action
ChowChow Cloud International Holdings Limited has issued a formal response following unusual trading activity in its shares, details remain developing.
Tenax Therapeutics Announces Presentation Of Phase 3 LEVEL Results In Late-Breaking Scientific Sessions At ESC Congress 2026
Tenax Therapeutics announced the presentation of Phase 3 LEVEL trial results during late-breaking sessions at ESC Congress 2026, highlighting key data on its experimental therapy.